Clinical Trial Update: Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study [Phase 2]

View source ↗

Summary

Phase II trial evaluating surufatinib in combination with sintilimab for advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Sintilimab (sintilimab)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: UNKNOWN